- Q3 2022 Nabriva Therapeutics PLC Earnings Call TranscriptNov 10, 2022€2.2 (-3.51%)Earnings
- Q2 2022 Nabriva Therapeutics PLC Earnings Call TranscriptAug 03, 2022€4.53 (+11.73%)Earnings
- Q1 2022 Nabriva Therapeutics PLC Earnings Call TranscriptMay 05, 2022€7.05 (+2.92%)Earnings
- Q4 2021 Nabriva Therapeutics PLC Earnings Call TranscriptMar 29, 2022€10.5 (-1.87%)Earnings
- Q3 2021 Nabriva Therapeutics PLC Earnings Call TranscriptNov 09, 2021€27.5Earnings
- Q2 2021 Nabriva Therapeutics PLC Earnings Call TranscriptAug 05, 2021€25.25 (-1.94%)Earnings
- Q1 2021 Nabriva Therapeutics PLC Earnings Call TranscriptMay 06, 2021€32.5 (-5.11%)Earnings
- Q4 2020 Nabriva Therapeutics PLC Earnings Call TranscriptMar 11, 2021€36.5 (-1.35%)Earnings
- Q3 2020 Nabriva Therapeutics PLC Earnings Call TranscriptNov 05, 2020€100 (+0.03%)Earnings
- Q2 2020 Nabriva Therapeutics PLC Earnings Call TranscriptAug 06, 2020€168 (+1.51%)Earnings
- Nabriva Therapeutics PLC at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 13, 2020
- Q1 2020 Nabriva Therapeutics PLC Earnings Call TranscriptMay 11, 2020€151.25 (+17.48%)Earnings
- Q4 2019 Nabriva Therapeutics PLC Earnings Call TranscriptMar 12, 2020€237.5 (-12.04%)Earnings
- Q3 2019 Nabriva Therapeutics PLC Earnings Call TranscriptNov 12, 2019€445Earnings
- Nabriva Therapeutics PLC at Morgan Stanley Healthcare Conference TranscriptSep 09, 2019
- Nabriva Therapeutics plc - Special Call TranscriptAug 19, 2019
- Nabriva Therapeutics PLC at Bank of America Merrill Lynch Health Care Conference TranscriptMay 15, 2019
- Nabriva Therapeutics plc Complete Response Letter from FDA on NDA Conference Call TranscriptMay 01, 2019
Q1 2022 Nabriva Therapeutics PLC Earnings Call Transcript
Good afternoon, ladies and gentlemen, and welcome to the Nabriva Therapeutics First Quarter 2022 Earnings Call. (Operator Instructions) As a reminder, this conference call is being recorded.
I would now like to turn the call over to Dan Dolan, Nabriva's Chief Financial Officer. You may begin.
Thank you, Gretchen, and good afternoon, everyone. Welcome to Nabriva's conference call and webcast where we will be discussing the first quarter 2022 earnings and providing a business update. The slides for today's presentation are posted on the company's website, www.nabriva.com, and can be found under the Investors tab in the Events & Presentations section. We recommend that you refer to the presentation, as we will be using those slides for today's discussion.
Before we begin, on Slide 2, I would like to remind everyone that this conference call and webcast will contain forward-looking statements about the company. These statements are
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)